Nature Reviews Neurology

(ISSN: 1759-4758,1759-4766)

Articles Available on Medscape

 
 

Nature Reviews Neurology's Latest Table of Contents

2011 - 7 (11)

  • Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. 
  • Nasal markers of CNS-targeted drug activity. 
  • New methods to permeabilize the blood-brain barrier. 
  • A hexanucleotide repeat expansion in C9ORF72 links amyotrophic lateral sclerosis and frontotemporal dementia. 
  • Clinical diagnosis and management of amyotrophic lateral sclerosis. 
  • Exercise is effective as a nonpharmacological approach to reduce the frequency of migraines. 
  • Clinical genetics of amyotrophic lateral sclerosis: what do we really know? 
  • Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations. 
  • FSTL5--a new prognostic biomarker for medulloblastoma. 
  • A role for ubiquilin 2 mutations in neurodegeneration. 
  • How can we improve clinical trials in amyotrophic lateral sclerosis? 
  • Is GDNF beneficial in Parkinson disease? 
  • Epilepsy: Schizophrenia and epilepsy are bidirectionally related. 
  • Stroke: Comprehensive stroke centers abolish the weekend effect. 
  • Alzheimer disease: Benefits of an insulin nasal spray in Alzheimer disease and amnestic mild cognitive impairment. 
  • Motor neuron disease: Anatomical spread of amyotrophic lateral sclerosis predicts survival. 
  • Peripheral neuropathies: Progression-associated gene expression profiles in diabetic neuropathy. 
  • Multiple sclerosis: MicroRNA profiling reveals impaired neurosteroidogenesis. 
  • Stroke: Ischemic stroke on the rise in children and young adults. 
  • Motor neuron disease: Mutant SOD1 induces misfolding of the wild-type protein. 
 
 

Mission Statement: Nature Reviews Neurology commissions leaders in the field to write clinical content of the highest quality, authority and accessibility.

 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC. This website also contains material copyrighted by 3rd parties.